€430.90
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Vertex
sharewise wants to provide you with the best news and tools for Vertex, so we directly link to the best financial data sources.
Financials
News
3 No-Brainer Stocks to Buy in September
Don't want to think too hard about your investing decisions? Then go with the stocks of highly profitable companies with strong growth prospects.
Three Motley Fool contributors identified several
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Most investors are happy if a stock doubles within four or five years. Vertex Pharmaceuticals (NASDAQ: VRTX) shareholders should be ecstatic. Its share price has skyrocketed 140% over the last three
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
Novo Nordisk (NYSE: NVO) is enjoying one of the best seasons in its history. Two of the company's drugs, Ozempic and Wegovy, have become household names. Novo's sales and profits are soaring. So is
These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
Many stocks have been enjoying major gains as the bull market has persisted, driving up shares prices of companies across various indexes. If you're investing for the long term, what's more
3 Fantastic Growth Stocks to Buy in August
The recent stock market sell-off appears to have fizzled out and now could be a great time for long-term investors to put some of their cash to work.
Three Motley Fool contributors think they've
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Except for the last several days, the past 12 months have been pretty good for stocks across the board and especially successful for Vertex Pharmaceuticals (NASDAQ: VRTX). Shares of the biotech
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
When it comes to investing in the right companies for your portfolio, you need to ensure you select businesses that you understand and have the competitive advantages, financials, and leadership to
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
Few healthcare companies are more famous than Johnson & Johnson (NYSE: JNJ). The pharmaceutical giant earned its stature in the industry thanks to its incredible innovative abilities and a business
Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
Vertex Pharmaceuticals (NASDAQ: VRTX) has churned out nice profits quarter after quarter for years. The big biopharmaceutical company's cystic fibrosis (CF) franchise made it easy.
However, Vertex
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2024 Earnings CallAug 01, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
Great companies can deliver meaningful portfolio growth in a wide range of economic and market environments. From established companies to emerging businesses, the types of stocks you favor will
Is Vertex Pharmaceuticals' Monopoly in Danger?
Over the past decade, Vertex Pharmaceuticals (NASDAQ: VRTX) has delivered above-average returns. The secret behind the biotech's success isn't much of a secret. The drugmaker developed and marketed
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Vertex Pharmaceuticals (NASDAQ: VRTX) is trading near a record high after climbing about 20% so far this year, and delivering a triple-digit gain over three years. So, you may be a bit hesitant
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Vertex Pharmaceuticals (NASDAQ: VRTX) has made it to the major leagues in the world of biotech. The company is the leading maker of cystic fibrosis (CF) treatments, with its products generating more
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Any stock can have an impressive run, especially when broader equities are experiencing a bull market. Significantly fewer stocks can perform well through good and not-so-good times and deliver
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever
Growth stocks aren't created equal, but great businesses can stand the test of time in a portfolio and reward shareholders many times over through the years. Healthcare stocks with strong business
Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).
Vertex Pharmaceuticals (NASDAQ: VRTX) transformed the world of cystic fibrosis (CF) treatment when it launched its first product for the disease 12 years ago. Since then, it's built a CF treatment
1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever
Investing in equity markets is a reliable, wealth-growing strategy. In the past 33 years, the S&P 500's average annual return is about 10.6%. It's hard to find a return much better than that
Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
With Vertex Pharmaceuticals (NASDAQ: VRTX) announcing on June 21 that its therapy VX-880 helped nearly all of the patients with diabetes in a clinical trial to reduce or eliminate their need for
2 Superior Growth Stocks to Buy if You Have $1,000 Right Now
The stock market has its ups and downs -- and if you stay invested for decades, you will likely experience your fair share of both bull and bear markets. At the same time, by investing in a diverse
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Believe it or not, we're nearly halfway through this decade. The healthcare sector could be in store for monumental changes over the next few years.
These changes should present great opportunities
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) recently excited the medical community with clinical trial results from an experimental diabetes treatment it's developing. In a nutshell, it looks like a
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
Nearly everything is going right these days for Eli Lilly (NYSE: LLY). Sales and profits have been soaring. So has the share price, jumping more than 50% year to date after a 59% gain in 2023. Lilly
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation
Buying a stock with the intention of never selling it, or perhaps only selling it in a few decades, requires a level of conviction that most investments simply don't warrant. It's not enough to
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Have you ever felt anxiety about clicking the final button to buy a stock? Some investors agonize over their decisions. It doesn't have to be that way, though, if you find the right stocks.
Three